Atossa Genetics Inc buy Cantor Fitzgerald
Start price
20.06.24
/
50%
€1.03
Target price
20.06.25
-
Performance (%)
29.24%
Price
02.10.24
€1.33
Summary
This prediction is currently active. The prediction currently has a performance of 29.24%. This prediction currently runs until 20.06.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Atossa Genetics Inc | -1.632% | -1.632% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Atossa Genetics Inc diskutieren
Atossa Therapeutics, Inc. (NASDAQ: ATOS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for ATOS provided by MarketBeat